We are a family-established fund, which has no major structures, bureaucracy or overheads; everything we do is voluntary and is driven by our loss and our deep desire to improve the experience of Pancreatic Cancer sufferers and their families. Our family has been through this terrible experience and seen at first hand, just how devastating and cruel this disease can be. We are driven, as a family to help those sadly affected in whatever way we can.
Our mission is to improve survival rates, and quality of life for those diagnosed with Pancreatic Cancer and their families
The Elizabeth Coteman Fund was established at a pivotal time for Pancreatic Cancer. Whilst some real momentum is being achieved by leading researchers into its diagnosis and treatment, the survival and mortality statistics relating to Pancreatic Cancer remain appalling by comparison with the great and welcome advances made with other major cancers. The Coteman family is determined to see this imbalance addressed. So, in addition to our support for research, we want our experience of dealing with this disease to be available more directly to those diagnosed with pancreatic cancer and their families.
Our programme of support includes responding to financial hardship with varied and relevant grants where these are needed (for small household items, travel expenses, holidays or equipment that may make living with pancreatic cancer a little easier. We provide advocacy and friendship when individuals and families find themselves anxious, alone, or are finding it difficult to navigate clinical and care pathways, the benefits system, and other challenges. We are driven by the memory of our precious wife and mother, who is at the heart of everything we do.
Crucially, we are providing leadership in this most challenging area of cancer care; asking the difficult questions and not taking no for an answer.
Our work is carried out with a growing group of partners and associates; some of whom are working with a wide range of cancers, and others whose special focus is Pancreatic Cancer. We also work with those providing palliative and integrated care and others who will help us promote ‘upstream’ improvements in public health – e.g. up to 1 in 5 (20%) of Pancreatic Cancers may be linked to smoking.
